Synthesis and optimization of a novel series of HCV NS3 protease inhibitors: 4-Arylproline analogs-Reference-Cited by-同舟云学术

Synthesis and optimization of a novel series of HCV NS3 protease inhibitors: 4-Arylproline analogs

Published:2013-07 Issue:14 Volume:23 Page:4267-4271
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Bilodeau François,Bailey Murray D.,Bhardwaj Punit K.,Bordeleau Josée,Forgione Pat,Garneau Michel,Ghiro Elise,Gorys Vida,Halmos Ted,Jolicoeur Eric S.,Leblanc Mélissa,Lemke Christopher T.,Naud Julie,O’Meara Jeff,White Peter W.,Llinàs-Brunet Montse

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference37 articles.

1. The global burden of hepatitis C

2. Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome

3. Discovery and Development of VX-950, a Novel, Covalent, and Reversible Inhibitor of Hepatitis C Virus NS3.4A Serine Protease

4. Challenges in Modern Drug Discovery: A Case Study of Boceprevir, an HCV Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

5. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and Characterization of Novel Methyl (3)5-(N-Boc-piperidinyl)-1H-pyrazole-4-carboxylates;Molecules;2021-06-22

2. The index of ideality of correlation: QSAR studies of hepatitis C virus NS3/4A protease inhibitors using SMILES descriptors;SAR and QSAR in Environmental Research;2021-06-02

3. QSAR studies of the bioactivity of hepatitis C virus (HCV) NS3/4A protease inhibitors by multiple linear regression (MLR) and support vector machine (SVM);Bioorganic & Medicinal Chemistry Letters;2017-07

4. Structure-activity relationships of 4-hydroxy-4-biaryl-proline acylsulfonamide tripeptides: A series of potent NS3 protease inhibitors for the treatment of hepatitis C virus;Bioorganic & Medicinal Chemistry Letters;2017-02

5. The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection;Journal of Medicinal Chemistry;2014-03-05